349 related articles for article (PubMed ID: 36926338)
1. Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital.
Punzalan FER; Aherrera JAM; de Paz-Silava SLM; Mondragon AV; Malundo AFG; Tan JJE; Tantengco OAG; Quebral EPB; Uy MNAR; Lintao RCV; Dela Rosa JGL; Mercado MEP; Avenilla KC; Poblete JB; Albay AB; David-Wang AS; Alejandria MM
Front Immunol; 2023; 14():1123497. PubMed ID: 36926338
[TBL] [Abstract][Full Text] [Related]
2. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.
Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Hassan M; Rasheed U; Ahmed Khan S
Cureus; 2020 Aug; 12(8):e9575. PubMed ID: 32913691
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
Xu Y; Qian Y; Gu Q; Tang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
[TBL] [Abstract][Full Text] [Related]
4. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
[TBL] [Abstract][Full Text] [Related]
5. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs and cytokines as potential predictive biomarkers for COVID-19 disease progression.
Mohamed HA; Abdelkafy AE; Khairy RMM; Abdelraheim SR; Kamel BA; Marey H
Sci Rep; 2023 Mar; 13(1):3531. PubMed ID: 36864077
[TBL] [Abstract][Full Text] [Related]
8. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Prognostic Biomarkers of Coronavirus Disease 2019 in Children.
Önal P; Kılınç AA; Aygün FD; Aygün F; Durak C; Akkoç G; Ağbaş A; Elevli M; Çokuğraş H
J Trop Pediatr; 2022 Feb; 68(2):. PubMed ID: 35179604
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and outcome of Covid-19 illness and predictors of in-hospital mortality in Saudi Arabia.
Abolfotouh MA; Musattat A; Alanazi M; Alghnam S; Bosaeed M
BMC Infect Dis; 2022 Dec; 22(1):950. PubMed ID: 36526994
[TBL] [Abstract][Full Text] [Related]
11. Utility of Biochemical Markers in Predicting Severe COVID-19: Experience from a Tertiary Hospital in South India.
Shenoy MT; Mohanty PK; Suganthy K; Manavalan JK; Alexander H
EJIFCC; 2022 Aug; 33(2):131-144. PubMed ID: 36313911
[TBL] [Abstract][Full Text] [Related]
12. Effect of IL-6, IL-8/CXCL8, IP-10/CXCL 10 levels on the severity in COVID 19 infection.
Kesmez Can F; Özkurt Z; Öztürk N; Sezen S
Int J Clin Pract; 2021 Dec; 75(12):e14970. PubMed ID: 34626520
[TBL] [Abstract][Full Text] [Related]
13. The study of serum hsCRP, ferritin, IL-6 and plasma D-dimer in COVID-19: a retrospective study.
Ahirwar AK; Takhelmayum R; Sakarde A; Rathod BD; Jha PK; Kumawat R; Gopal N
Horm Mol Biol Clin Investig; 2022 Sep; 43(3):337-344. PubMed ID: 35357792
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort.
Ruytinx P; Vandormael P; Fraussen J; Pieters Z; Thonissen S; Hellings N; Stinissen P; Callebaut I; Penders J; Vanhove K; Kieffer D; Rummens JL; Valkenborgh T; Messiaen P; Stessel B; Mesotten D; Somers V
Sci Rep; 2023 Nov; 13(1):19322. PubMed ID: 37935729
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis.
Malik P; Patel U; Mehta D; Patel N; Kelkar R; Akrmah M; Gabrilove JL; Sacks H
BMJ Evid Based Med; 2021 Jun; 26(3):107-108. PubMed ID: 32934000
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.
Satış H; Özger HS; Aysert Yıldız P; Hızel K; Gulbahar Ö; Erbaş G; Aygencel G; Guzel Tunccan O; Öztürk MA; Dizbay M; Tufan A
Cytokine; 2021 Jan; 137():155302. PubMed ID: 33002740
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers and outcomes in hospitalised patients with COVID-19: a prospective registry.
Khedar RS; Gupta R; Sharma K; Mittal K; Ambaliya HC; Gupta JB; Singh S; Sharma S; Singh Y; Mathur A
BMJ Open; 2022 Dec; 12(12):e067430. PubMed ID: 36521904
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ-induced protein 10 (IP-10) and serum amyloid A (SAA) are excellent biomarkers for the prediction of COVID-19 progression and severity.
Haroun RA; Osman WH; Eessa AM
Life Sci; 2021 Mar; 269():119019. PubMed ID: 33454365
[TBL] [Abstract][Full Text] [Related]
19. Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone.
Mwangi VI; Netto RLA; de Morais CEP; Silva AS; Silva BM; Lima AB; Neves JCF; Borba MGS; Val FFAE; de Almeida ACG; Costa AG; Sampaio VS; Gardinassi LG; de Lacerda MVG; Monteiro WM; de Melo GC
Front Immunol; 2023; 14():1229611. PubMed ID: 37662953
[TBL] [Abstract][Full Text] [Related]
20. The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study From a Tertiary Care Hospital in India.
Dwivedi T; Raj A; Das N; Gupta R; Gupta N; Tiwari P; Sahoo B; Sagiraju HKR; Sirohiya P; Ratre B; Elavarasi A; Mohan A; Bhatnagar S
Cureus; 2023 Jun; 15(6):e40273. PubMed ID: 37448393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
